We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · December 30, 2019

Two-Year Outcomes of Inflammatory Choroidal Neovascularization Treated With Intravitreal Anti-VEGF: Comparing Two Treatment Regimens

The British Journal of Ophthalmology

 

Additional Info

The British Journal of Ophthalmology
Twenty-Four-Month Outcomes of Inflammatory Choroidal Neovascularisation Treated With Intravitreal Anti-Vascular Endothelial Growth Factors: A Comparison Between Two Treatment Regimens
Br J Ophthalmol 2019 Nov 19;[EPub Ahead of Print], A Invernizzi, F Pichi, R Symes, S Zagora, AK Agarwal, P Nguyen, S Erba, A Xhepa, L De Simone, L Cimino, MC Gillies, PJ McCluskey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading